Found 23 matching trials
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
PHASE1Subjects on this study have a type of lymph gland cancer called Non-Hodgkin...
Location
Houston Methodist Hospital
CD19-targeting, 3rd Generation CAR T Cells for Refractory B Cells Malignancy
PHASE2Treatment of patients with B cell lymphoma or leukemia with two doses of CD...
Location
Uppsala University Hospital, Dept of Oncology
ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL
NAThis open-label, non-randomized, phase II exploratory study aims to evaluat...
Location
Blood diseases hospital
A Study of Atlacabtagene Autoleucel CAR T-cells for Adults With Relapsed Large B-cell Lymphoma
PHASE2The goal of this clinical trial is to learn if a new type of chimeric antig...
Location
Auckland City Hospital
ENABLE-1 (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen Receptor Therapy)
PHASE1This Phase 1, single centre, open label dose escalation study aims to ident...
Status
Active Not Recruiting
Location
Wellington Hospital, Te Whatu Ora Health New Zealand Capital Coast & Hutt Valley
IASO207 Injection in the Treatment of Relapsed/Refractory B-cell Malignancies
EARLY_PHASE1This is a single-center, open-label, exploratory clinical study to evaluate...
Location
Peking University People's Hospital
IASO207 Injection for Active Refractory Systemic Lupus Erythematosus (SLE)
EARLY_PHASE1This is a single-center, open-label, exploratory clinical study designed to...
Location
Peking University People's Hospital
Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR
PHASE1Adult patients with r/r acute lymphoblastic leukemia (ALL) (stratum I), r/r...
Location
University Hospital Heidelberg
the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune Diseases
EARLY_PHASE1This study is designed as a single arm, open label, single center clinical ...
Location
Tongji Hospital, Affiliated to Tongji Medical College of Huazhong University of Science and Technology
Full-Course Immunotherapy Consolidation for Unfit or Fit B-ALL Who Decline Chemotherapy
PHASE2This trial is a non-blinded, single-center, open-label, single-arm clinical...
Location
The First Affiliated Hospital of Soochow University